NRAS and melanoma: Interestingly, we demonstrated a selective effect of LY500307 in melanoma cell lines in terms of cell cycle blockage, apoptosis induction and partial EMT reversion, with particular reference to those expressing ERβ in NRAS-mutated genetic background.